l-Arginine in diabetic cardiomyopathy: Mechanistic insights into RAGE-NF-κB-SREBP1 signaling

Biochem Biophys Res Commun. 2025 Dec 24;797:153212. doi: 10.1016/j.bbrc.2025.153212. Online ahead of print.ABSTRACTIn diabetes, glycation exacerbates low-grade inflammation and lipotoxicity, driving the development and progression of diabetic cardiomyopathy (DCM). l-Arginine (L-Arg) supplementation

M Muskan R Thakur

Feeling Blue and Trying Not to Lose Heart: Associations Between Mental Health and Cardiovascular Health Groups for Black Young Adult Women

Biopsychosoc Sci Med. 2026 Jan 1;88(1):100-112. doi: 10.1097/PSY.0000000000001415. Epub 2025 Sep 26.ABSTRACTOBJECTIVE: Black women in the United States experience a high burden of incident cardiovascular (CV) disease, yet research often focuses on midlife and beyond. One psychological correlate of C

V Vanessa V Volpe

Sex and Gender Issues in Cardiovascular Disease: Introduction to a Special Issue

No abstractBiopsychosoc Sci Med. 2026 Jan 1;88(1):3-5. doi: 10.1097/PSY.0000000000001460. Epub 2025 Nov 28.NO ABSTRACTPMID:41461107 | DOI:10.1097/PSY.0000000000001460

N Nina Kupper

Modified deployment of a self-expanding aortic endoprosthesis for congenital aortic and conduit repair applications

No abstractJ Invasive Cardiol. 2025 Dec 22. doi: 10.25270/jic/25.00368. Online ahead of print.NO ABSTRACTPMID:41461099 | DOI:10.25270/jic/25.00368

J Jason H Anderson

Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study

Ann Intern Med. 2025 Dec 30. doi: 10.7326/ANNALS-25-00662. Online ahead of print.ABSTRACTBACKGROUND: Whether statins benefit patients with type 2 diabetes mellitus (T2DM) with low predicted 10-year cardiovascular risk is uncertain.OBJECTIVE: To evaluate the effectiveness and safety of statin initiat

V Vincent Ka Chun Yan

2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease

Ann Intern Med. 2025 Dec 30. doi: 10.7326/ANNALS-25-03499. Online ahead of print.ABSTRACTDESCRIPTION: Management of chronic kidney disease (CKD) has been rapidly evolving, now involving many interventions that can be managed in the primary care setting. In April 2025, leadership within the U.S. Depa

A Amy R Schwartz

Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy

Neurology. 2026 Jan 27;106(2):e214489. doi: 10.1212/WNL.0000000000214489. Epub 2025 Dec 29.ABSTRACTOBJECTIVES: Anticoagulants and thrombolytics may interact with anti-amyloid monoclonal antibodies (mAbs) to increase intracranial hemorrhage risk, so expert guidance recommends against their co-prescri

A Anna L Parks

Association Between Circadian Rest-Activity Rhythms and Incident Dementia in Older Adults: The Atherosclerosis Risk in Communities Study

Neurology. 2026 Jan 27;106(2):e214513. doi: 10.1212/WNL.0000000000214513. Epub 2025 Dec 29.ABSTRACTBACKGROUND AND OBJECTIVES: Aging is associated with changes in circadian rhythms. Rest-activity rhythms (RARs) measured using accelerometers are markers of circadian rhythms. Altered circadian rhythms

W Wendy Wang

Association of Plasma GFAP and NfL in Middle-Aged Adults With MRI Markers of Cerebral Small Vessel Disease Later in Life

Neurology. 2026 Jan 27;106(2):e214481. doi: 10.1212/WNL.0000000000214481. Epub 2025 Dec 29.ABSTRACTBACKGROUND AND OBJECTIVES: Cerebral small vessel disease (cSVD) is a major contributor to stroke and dementia, often beginning decades before clinical symptoms appear. While MRI markers offer critical

S Savvina Prapiadou

Innovations in robotic aortic valve surgery

Curr Opin Cardiol. 2025 Dec 30. doi: 10.1097/HCO.0000000000001272. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: This review explores the contemporary minimally invasive strategies in management of aortic valve disease, highlighting the innovative advancements in robotic approaches, particularly

A Ali Darehzereshki

Cardiometabolic benefits of replacing saturated fatty acids with unsaturated fatty acids

Curr Opin Clin Nutr Metab Care. 2025 Dec 30. doi: 10.1097/MCO.0000000000001195. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: To inform about the current evidence on the potential cardiometabolic benefits of replacing saturated fatty acids with unsaturated fatty acids. This review will highlight

U Ulf Risérus

Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation

Circulation. 2026 Jan 6;153(1):35-46. doi: 10.1161/CIRCULATIONAHA.125.077494. Epub 2025 Nov 8.ABSTRACTBACKGROUND: Drug-induced QT prolongation after successful inpatient loading of class III antiarrhythmics may occur during routine outpatient care. Insertable cardiac monitors offer continuous signal

R Rayan A Ansari

Minimally invasive coronary artery bypass grafting (MINI-CABG): Protocol for a pilot randomized controlled trial comparing minimally invasive versus conventional coronary surgery

PLoS One. 2025 Dec 29;20(12):e0337829. doi: 10.1371/journal.pone.0337829. eCollection 2025.ABSTRACTINTRODUCTION: Coronary artery bypass grafting (CABG) via sternotomy remains the standard of care for multivessel coronary disease. Minimally invasive cardiac surgery for coronary artery bypass grafting

L Luis Roberto Palma Dallan

Global, regional, and national burden of kidney dysfunction-attributed ischemic heart disease from 1990 to 2021: A systematic analysis of the Global Burden of Disease study 2021

PLoS One. 2025 Dec 29;20(12):e0335548. doi: 10.1371/journal.pone.0335548. eCollection 2025.ABSTRACTBACKGROUND: Ischemic heart disease (IHD) remains a leading cause of global morbidity and mortality, with kidney dysfunction (KD) emerging as a critical independent risk factor. This study aimed to prov

H Huaipeng Zhang

Prevalence and incidence of Coats disease in a large claims database

PLoS One. 2025 Dec 29;20(12):e0329871. doi: 10.1371/journal.pone.0329871. eCollection 2025.ABSTRACTPURPOSE: To determine the prevalence and incidence of Coats disease in the Japan Medical Data Center (JMDC) claims database.METHODS: Data on patients with Coats disease were collected from the JMDC cla

N Nobuhisa Ochiai

The PREHAAAB Trial: Multimodal prehabilitation for patients awaiting open abdominal aortic aneurysm repair - A study protocol for an international randomized controlled trial

PLoS One. 2025 Dec 29;20(12):e0339473. doi: 10.1371/journal.pone.0339473. eCollection 2025.ABSTRACTBACKGROUND: Patients undergoing open abdominal aortic aneurysm (AAA) repair remain at high risk for postoperative complications, particularly when presenting with limited baseline functional capacity.

M Miquel Coca-Martinez

Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in Chronic Kidney Disease (CKD Dragon-Registry)

PLoS One. 2025 Dec 29;20(12):e0337991. doi: 10.1371/journal.pone.0337991. eCollection 2025.ABSTRACTWe sought to investigated the outcomes of patients with chronic kidney disease (CKD) and drug-eluting stent (DES)-in-stent restenosis (ISR) undergoing percutaneous coronary intervention (PCI) with a dr

R Rafał Januszek

Assessment of hypertension and diabetes among lecturers in a Ghanaian university: Setting lifestyle practices as precursors

PLoS One. 2025 Dec 29;20(12):e0338910. doi: 10.1371/journal.pone.0338910. eCollection 2025.ABSTRACTINTRODUCTION: Research works relating to the lifestyle of students, non-academic staff, and communities have had considerable attention. However, studies on the lifestyles of university lecturers in Gh

J Joseph Kwasi Brenyah

Trends in statin prescription among osteoporosis patients: A retrospective cohort study using UK primary care data

PLOS Glob Public Health. 2025 Dec 29;5(12):e0005656. doi: 10.1371/journal.pgph.0005656. eCollection 2025.ABSTRACTStatin prescribing patterns in osteoporosis patients remain uncharacterized despite cardiovascular disease being a leading cause of mortality in this population. This study examined tempo

I Ingrid Mei-Fung Wong

The immune checkpoint inhibitor avelumab increases aortic inflammation on [18F]FDG PET/CT: A retrospective cohort study

PLoS One. 2025 Dec 29;20(12):e0339671. doi: 10.1371/journal.pone.0339671. eCollection 2025.ABSTRACTBACKGROUND: Patients with cancer treated with immune checkpoint inhibitors (ICIs) are at increased risk of cardiovascular events. Preclinical studies suggest that this may result from inflammation-indu

A Anniek Strijdhorst

Diet-induced steatohepatitis does not cause heart failure with preserved ejection fraction in male middle-aged C57BL/6N mice

PLoS One. 2025 Dec 29;20(12):e0339642. doi: 10.1371/journal.pone.0339642. eCollection 2025.ABSTRACTMetabolic dysfunction-associated steatohepatitis (MASH) is a condition characterized by inflammation and liver fibrosis. MASH patients are at a high risk of developing heart failure with preserved ejec

C Chase W Kessinger

Outcomes with Revascularization vs. Medical Therapy According to Plaque Burden from Coronary Computed Tomography Angiography

Eur Heart J Cardiovasc Imaging. 2025 Dec 29:jeaf372. doi: 10.1093/ehjci/jeaf372. Online ahead of print.ABSTRACTAIMS: We aimed to investigate, whether plaque burden from coronary computed tomography angiography (CCTA) could be used to identify patients potentially benefitting from revascularization.M

S Sarah Bär

A Methodological Protocol and Considerations for Transcranial Ultrasonic Stimulation in Exploratory Clinical Human Studies

J Vis Exp. 2025 Dec 12;(226). doi: 10.3791/69236.ABSTRACTTranscranial ultrasonic stimulation (TUS) is emerging as a non-invasive neuromodulatory technique capable of delivering millimeter-precision stimulation at whole-brain depths. Research efforts have increasingly focused on its translational pot

Z Ziping Huang

A Case of Cardiac Sarcoidosis Presenting with a Low-level Elevation of Troponin: Case Report and Literature Review

J Vis Exp. 2025 Dec 12;(226). doi: 10.3791/69381.ABSTRACTCardiac sarcoidosis (CS) is a rare complication of systemic sarcoidosis, which can occur independently or concurrently with systemic sarcoidosis. The clinical manifestations range from asymptomatic myocardial granulomas to arrhythmias, heart f

L Li Sun